
|Articles|May 1, 2001
Supplements and Featured Publications
- Artherosclerosis: Achieving Optimal Outcomes in Statin Therapy
- Volume 7
- Issue 5 Suppl
What Do the Statin Trials Tell Us?
Author(s)David D. Waters, MD
Advertisement
Articles in this issue
almost 25 years ago
Participating Facultyalmost 25 years ago
Introductionalmost 25 years ago
Should All Patients with Cardiovascular Disease Receive Statin Therapy?almost 25 years ago
Threshold Level or Not for Low-Density Lipoprotein Cholesterolalmost 25 years ago
Statins--Differences and Similaritiesalmost 25 years ago
Surrogate Endpoints and Newer Risk Markers in Atherosclerosis Managementalmost 25 years ago
New Therapies on the Horizonalmost 25 years ago
A New Statin: A New StandardNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
Understanding Real-World MRI Utilization for ED Dizziness: Ava L. Liberman, MD
5









